Suchergebnisse - "Nazeri, Masoume"

PubPharm (7)

1

Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis : A Phase IV, Post-marketing, Prospective, Multicenter Study

enthalten in: Archives of Iranian medicine | 2023

von Naser Moghadasi, A. | Ashtari, F. | Baghbanian, S. | +14

2

Serum inflammatory markers in patients with multiple sclerosis and their association with clinical manifestations and MRI findings

enthalten in: Acta neurologica Belgica | 2022

von Nazeri, M. | Bazrafshan, H. | Abolhasani Foroughi, A.

3

Serum inflammatory markers in patients with multiple sclerosis and their association with clinical manifestations and MRI findings

enthalten in: Acta neurologica Belgica | 2021

von Nazeri, M. | Bazrafshan, H. | Abolhasani Foroughi, A.

4

Serum inflammatory markers in patients with multiple sclerosis and their association with clinical manifestations and MRI findings

enthalten in: Acta neurologica Belgica | 2021

von Nazeri, M. | Bazrafshan, H. | Abolhasani Foroughi, A.

5

Serum inflammatory markers in patients with multiple sclerosis and their association with clinical manifestations and MRI findings

enthalten in: Acta neurologica Belgica | 2021

von Nazeri, M. | Bazrafshan, H. | Abolhasani Foroughi, A.

6

Correlation between contrast enhanced plaques and plaque diffusion restriction and their signal intensities in FLAIR images in patients who admitted with acute symptoms of multiple sclerosis

enthalten in: Journal of medical imaging and radiation sciences | 2021

von Foroughi, A. | Zare, N. | Saeedi-Moghadam, M. | +2

7

Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis

enthalten in: The neuroradiology journal | 2017

von Abolhasani Foroughi, A. | Salahi, R. | Nikseresht, A. | +3

1
[1]